Trending now:  
Redo-TAVR with balloon-expandable valves: outcomes from a national registry
ORBITA 2: The power of PCI revealed for stable angina
TCT 2023 Highlights
AHA 2023 Highlights
OCT vs angiography in patients with diabetes and complex lesions

Content for healthcare professionals only

News |

Cardiac resynchronisation in heart failure with right ventricular pacing

06 Nov 2023

The BUDAPEST CRT Upgrade trial marked the pioneering attempt to evaluate the efficacy and safety of a cardiac resynchronization therapy (CRT) upgrade in comparison to intracardiac defibrillator (ICD)-only treatment. This evaluation was conducted in patients with heart failure and reduced ejection fraction (HFrEF) who already had a pacemaker or ICD and experienced intermittent or permanent RV pacing.

Researchers concluded that the implementation of cardiac resynchronization therapy with a defibrillator (CRT-D) as an upgrade has shown to decrease morbidity and mortality while also promoting the improvement of left ventricular reverse remodeling. This is particularly beneficial for patients with heart failure and reduced ejection fraction (HFrEF) who experience intermittent or permanent right ventricular (RV) pacing.

For more cardiology research news join our newsletter or follow us on TwitterFacebookLinkedIn or Instagram.


Related Topics

Related Articles